Avidity Partners Management LP Gilead Sciences, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$63.15 - $72.88 $16.1 Million - $18.6 Million
255,000 New
255,000 $17.5 Million
Q2 2020

Aug 14, 2020
SELL
$72.34 - $84.0 $14.5 Million - $16.8 Million
-200,000 Closed
0 $0
Q1 2020

Jun 17, 2020
BUY
$62.63 - $80.22 $12.5 Million - $16 Million
200,000 New
200,000 $15 Million

Others Institutions Holding GILD

# of Institutions
1,927
Shares Held
994M
Call Options Held
10.5M
Put Options Held
9.75M
View Full List

About GILEAD SCIENCES, INC.

GILD Quotes by TradingView
  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email